DIABETIC MACULAR EDEMA (DME)
Clinical trials for DIABETIC MACULAR EDEMA (DME) explained in plain language.
Never miss a new study
Get alerted when new DIABETIC MACULAR EDEMA (DME) trials appear
Sign up with your email to follow new studies for DIABETIC MACULAR EDEMA (DME), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Beovu shows promise in Real-World eye disease study
Disease control CompletedThis study looked at how well the drug Beovu (brolucizumab) works in everyday medical practice for people with two eye diseases: wet age-related macular degeneration and diabetic macular edema. Researchers followed 572 patients who were already prescribed Beovu by their doctor, t…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 07:12 UTC
-
New eye drug shows promise for blinding conditions
Disease control CompletedThis study tested a new medicine called EYE103, given as an eye injection, for people with diabetic macular edema (DME) or wet age-related macular degeneration (NVAMD). The goal was to check safety and see if it helps improve vision. About 33 adults took part, with DME patients r…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE1, PHASE2 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated May 26, 2026 07:02 UTC
-
New eye drug OLN324 shows promise in early trial for two blinding diseases
Disease control CompletedThis early-phase study tested a new eye injection called OLN324 in 164 adults with either wet age-related macular degeneration (AMD) or diabetic macular edema (DME). The main goal was to check safety and how the drug moves through the body, while also looking for early signs it m…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Phase: PHASE1 • Sponsor: Ollin Biosciences, Inc. • Aim: Disease control
Last updated May 04, 2026 16:17 UTC
-
Eye injection study reveals hidden patient burdens
Knowledge-focused CompletedThis study looked at how much of a burden patients feel from repeated eye injections for three different eye diseases: wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. Researchers interviewed 393 patients who had at least five injections o…
Matched conditions: DIABETIC MACULAR EDEMA (DME)
Sponsor: Hospital Hietzing • Aim: Knowledge-focused
Last updated May 26, 2026 07:03 UTC